News

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. Through these we unite the entire early-stage R&D ecosystem with a shared mission: to accelerate the discovery and development of transformative, life-changing medicines.

Revolutionary Eye Implant Gives Blind Patients A New lease of Life

See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery

Drug Development

From Drug Product Development to Overcoming Regulatory Hurdles

Drug Development

Intellectual Property in the Innovation Pipeline: Lessons from the “IP Considerations in Early Discovery & Development” Roundtable

Gain Therapeutics Reports Early Findings on GT-02287 in Parkinson’s Disease

Drug Development

Sustainable Impact of Drug Delivery Methods

Advanced Tools & Tech for Drug Discovery

Nobel Prize in Chemistry 2025 Awarded to Work on Metal–Organic Frameworks

Elix and Tohoku University Forge Joint Research Agreement in AI-Powered Drug Discovery

Drug Development

METiS Launches World’s First AI-Driven Nano-Delivery Platform NanoForge

Emma Walmsley to Step Down as CEO of GSK After a Remarkable Run

Unlocking the Brain- Innovations in CNS Drug Discovery and Neurodegenerative Treatment

New AI Tool Maps Viral RNA in 3D at Molecular Level

Drug Development

Sanofi Throws Its Weight Behind Vicebio in £1.2 Billion Vaccine Deal

Transatlantic Tech Prosperity Deal to Boost Drug Discovery Efforts and Drive Employment

Seaport Therapeutics’ Anxiety Drug Dosed in First Patient

Researchers Engineer Self-Organising Ureter Structures from Stem Cells

Drug Development

Mucus Microspheres Offer the Promise of Adhesive and Sustained Drug Delivery

OpenAI and Retro Bioscience’s Cellular Reprogramming Research Uncovers Novelties in Longevity Research

Drug Development

BioArctic’s BrainTransporter Platform Rewrites the Rules of Neurodegeneration Drug Delivery

New Schizophrenia Trial Targets Cognitive Impairment in Clinical Risk Individuals

MIT Researchers Use AI to Outsmart Gonorrhoea and MRSA Superbugs